Roche Diagnostics Purchases Microarray Instrument and Accessory Assets from BioMicro SystemsBusiness Wire, 11.03.2010
Roche Diagnostics (SIX:
RO, ROG; OTCQX: RHHBY) has purchased assets from BioMicro Systems
for all products associated with the Roche NimbleGen microarray
workflow. These assets consist of key instrumentation in the
comprehensive Roche NimbleGen microarray workflow including the
NimbleGen Hybridization Systems (both 4- and 12-bay models). Also
included in this purchase are array accessories covering all mixers
designed for the Roche NimbleGen high-density microarray portfolio.
Roche Diagnostics will continue to provide global sales, service, and
support for all products in the NimbleGen microarray workflows.
more 
